Hematologic Cancer News and Features

A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma

A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma

Older age is associated with worse prognosis in patients with early-stage Burkitt lymphoma, according to study authors.

Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma

Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma

This study sought to determine the noninferiority of 2 hours of cryotherapy vs standard 7 hours prior to high-dose melphalan before autologous HSCT.

Lymphoma Survivors Experience Special Needs During Transition to Survivorship Care

Lymphoma Survivors Experience Special Needs During Transition to Survivorship Care

A qualitative study revealed the unique needs of lymphoma survivors transitioning from active care to survivorship.

Performance of Work-Related Functions Linked to Cancer Treatment in Adolescent, Young Adult Survivors

Performance of Work-Related Functions Linked to Cancer Treatment in Adolescent, Young Adult Survivors

Survey results reveal the effects of cancer treatment on job-related mental and physical abilities in survivors who were AYAs at diagnosis.

Analysis of Older Patients With AML Shows Benefit of Decitabine Treatment in a Real-World Setting

Analysis of Older Patients With AML Shows Benefit of Decitabine Treatment in a Real-World Setting

Researchers present data on the efficacy and safety of decitabine in older patients with acute myeloid leukemia.

Gastrointestinal Perforation Complicates Management of Mantle Cell Lymphoma

Gastrointestinal Perforation Complicates Management of Mantle Cell Lymphoma

A patient case illustrates the need for high suspicion of GI perforation and patient education on symptoms of potential adverse effects in certain patients with gastrointestinal lymphoma.

FDA Approves Tagraxofusp, First Approved Treatment for a Rare, Aggressive Hematologic Cancer

FDA Approves Tagraxofusp, First Approved Treatment for a Rare, Aggressive Hematologic Cancer

FDA grants approval to tagraxofusp-erzs (Elzonris), a first treatment for blastic plasmacytoid dentritic cell neoplasm and the first therapy to target CD123.

High Expression of DNA Repair Genes at Diagnosis Predictive of Early Relapse in Pediatric ALL

High Expression of DNA Repair Genes at Diagnosis Predictive of Early Relapse in Pediatric ALL

A data analysis revealed a genetic predictor of relapse for pediatric patients with ALL.

Risk of Therapy-Related MDS, AML Increased by Use of Leukemogenic Chemotherapy Agents

Risk of Therapy-Related MDS, AML Increased by Use of Leukemogenic Chemotherapy Agents

Researchers sought to determine the association between chemotherapy, particularly platinum-based agents, and increased risk of tMDS/AML.

Mini-Pools of IVIG Just as Effective as Standard IVIG in Pediatric Immune Thrombocytopenia

Mini-Pools of IVIG Just as Effective as Standard IVIG in Pediatric Immune Thrombocytopenia

Intravenous immunoglobulin G with plasma from fewer blood donations provides sufficient therapeutic effect for pediatric patients with ITP.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs